Weekly News Recap #Phispers
Mallinckrodt, Endo merge in US$ 6.7 bn deal; Astra buys cell therapy developer EsoBiotec; Pfizer sells entire stake in Haleon
In Phispers this week, two drugmakers emerging from bankruptcy — Mallinckrodt and Endo — are merging in order to le...
Impressions : 1328
CDC finds Moderna to be most effective Covid jab; two Indian CROs under FDA lens over data integrity issues
This week, Phispers brings you updates on Covid vaccines,
news on regulatory actions, legal battles involving drugmakers and d...
Impressions : 1640
BMS buys biopharma firm MyoKardia for US$ 13.1 billion; Concerns emerge over quality of acetazolamide
This week, Phispers has more updates on Covid-19 vaccines and therapies.
In the US, President Donald Trump contracted the vir...
Impressions : 88812
Sanofi overhauls executive committee; FDA recalls metformin due to unacceptable levels of NDMA impurity
This week, Phispers brings news on various developments across the world as a result of the Covid-19 pandemic.
While US Presi...
Impressions : 89389
EMA raises clinical data-integrity concerns at Indian CRO; Sandoz to pay record US$ 195 million fine
This week, Phispers has more updates on Covid-19.
While US lawmakers approved an emergency bill of US$ 8.3 billion to fund th...
Impressions : 3253
Merck spins off slow-growing drugs into US$ 6.5 billion firm; Aurobindo’s facility gets classified as OAI
This week, Phispers brings you news on Merck as the drugmaker spun off its slowing-growing drugs into a new drug company with U...
Impressions : 3500
After sartans, diabetes drug metformin being tested for cancer causing impurities; FDA’s overseas inspections drop
This week in Phispers, we bring you the major announcements made by Sanofi’s new CEO Paul Hudson at its strategy meet.
...
Impressions : 2742
Amneal co-founders return to run company; Drug industry urges Canada to act on US drug import plan
This week, Phispers has news from Canada, where its drug lobby group has urged the government to take bold steps like banning d...
Impressions : 2058
PhRMA publishes list of US cancer drug pipeline; Biocon-Mylan’s Neulasta biosim bags FDA nod
This week in Phispers, Biocon–Mylan scored a big win by getting the FDA nod for its biosimilar to Amgen’s Neulasta....
Impressions : 2468
2017 closes with record approvals of generics, novel drugs; 2018 begins with reprieves for Teva
PharmaCompass wishes its readers a very happy new year. We begin the year with an analysis of 2017, when we saw record approval...
Impressions : 4358
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.